Uvodnik

COVID-19 treatment: High time for Antimicrobial Stewardship Program

Nenad Pandak orcid.org/0000-0002-4379-6219 ; Medicine Department, Infectious Disease Unit, Royal Hospital, Muscat, Oman
Vladimir Krajinović ; Department of Intensive Care Medicine and Neuroinfectology, University Hospital for Infectious Diseases “Dr. Fran Mihaljević”, Zagreb, Croatia

Sažetak

Last several months, the World is witnessing Coronavirus disease 2019 (COVID-19) pandemic caused by the newly identified Coronavirus. Due to the fast and easy disease spread as well as its severity, currently this pandemic is dominating every aspect of the global healthcare systems but also it outstandingly influences every side of our lives including the global economy. Almost all COVID-19 treatment guidelines advocate the rational use of antibiotics, but if we analyse the reports published so far, it is evident that about 70% up to even 100% of patients are treated with antibiotics. This antibiotic misuse highlights the urgent need for launching the Antimicrobial Stewardship Program in order to monitor the appropriate use of antibiotics. In this article, the authors suggest the postulates for implementing the antibiotic stewardship in COVID-19 patients.

Ključne riječi

COVID-19; antibiotics; Antibiotic Stewardship Program

Hrčak ID:

252501

URI

https://hrcak.srce.hr/252501

Datum izdavanja:

22.2.2021.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.302 *